Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 60Neoplasms 58Lung Neoplasms 32Prostatic Neoplasms 24Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 21Neoplastic Cells, Circulating 20Head and Neck Neoplasms 19Pancreatic Neoplasms 17Melanoma 14Ovarian Neoplasms 13Carcinoma, Hepatocellular 12Esophageal Neoplasms 10Colonic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Glioma 9Squamous Cell Carcinoma of Head and Neck 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Sarcoma 7Neoplasm Metastasis 7Endometrial Neoplasms 7Stomach Neoplasms 6Neoplasm, Residual 6Myeloproliferative Disorders 6Leukemia 6Kidney Neoplasms 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6

Interventions

Tinzaparin 1Therapeutics 1Psychiatric Rehabilitation 1Fentanyl 1Drug Therapy 1Dapsone 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphoproliferative Disorders × Blood Specimen Collection × Clear all
NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡